Two short peptides developed in Russian neuropharmacology labs that have built a substantial research literature. BDNF effects, anxiolytic-like activity, and the open mechanistic questions.
Temperature targets, aliquoting against freeze-thaw, light and oxygen protection, container choice, and the documentation that catches assay drift before it ruins data.
A 16-residue peptide encoded inside mitochondrial DNA that activates AMPK and reshapes the metabolic conversation. What the literature says and where the field is heading.
